产品中心 抗体 其他一抗

所有图片(1/8)

BRCA1 Recombinant Mouse mAb (S-4707)

Breast cancer type 1 susceptibility protein,RING finger protein 53,RING-type E3 ubiquitin transferase BRCA1,RNF53

价格 600.00 供应商现货 : 3-5个工作日
货号 S0B6791
规格
数量
收藏 分享

产品介绍 评论(0)

产品规格
  • 宿主来源

    Mouse
  • 抗原名称

    BRCA1
  • 分子别名

    Breast cancer type 1 susceptibility protein; RING finger protein 53; RING-type E3 ubiquitin transferase BRCA1; RNF53
  • 细胞定位

    Nucleus, Cytoplasm
  • Accession

    P38398
  • 克隆号

    S-4707
  • 抗体类型

    Mouse mAb
  • 抗体同种型

    IgG1,k
  • 反应种属 ?

    Hu
  • 纯化方式

    Protein G
  • 浓度

    2 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300

  • 储存条件

    12 months from date of receipt / reconstitution, -20 °C as supplied

  • 应用

    IHC-P ?

    ICC ?

  • 稀释度

    应用 稀释度 推荐种属
    IHC-P 1:1000 Hu
    ICC 1:2000 Hu
背景介绍
  • BRCA1 (Breast Cancer gene 1) is a critical tumor suppressor protein encoded by the BRCA1 gene in humans, playing an indispensable role in maintaining genomic stability primarily through its involvement in the high-fidelity repair of double-strand DNA breaks via homologous recombination. Functioning as a scaffold within a large multiprotein complex, BRCA1 interacts with key partners such as BARD1, PALB2, and RAD51 to coordinate cell cycle checkpoints, particularly at the G2/M transition, ensuring that cells do not divide with damaged DNA, while also participating in transcriptional regulation and ubiquitination processes; consequently, inherited loss-of-function mutations in the BRCA1 gene severely compromise these DNA repair mechanisms, leading to an accumulation of genetic errors and a significantly elevated lifetime risk of developing hereditary breast and ovarian cancers, which has made the protein a central focus for both genetic screening protocols and the development of targeted therapies like PARP inhibitors that exploit synthetic lethality in BRCA1-deficient tumors.

  • 免疫组化

    • IHC shows positive staining in paraffin-embedded human breast. Anti-BRCA1 antibody was used at 1/1000 dilution, followed by a HRP Polymer for Mouse IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • IHC shows positive staining in paraffin-embedded human breast cancer (case 1). Anti-BRCA1 antibody was used at 1/1000 dilution, followed by a HRP Polymer for Mouse IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • IHC shows positive staining in paraffin-embedded human breast cancer (case 2). Anti-BRCA1 antibody was used at 1/1000 dilution, followed by a HRP Polymer for Mouse IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • IHC shows negative staining in paraffin-embedded human breast cancer (case 3). Anti-BRCA1 antibody was used at 1/1000 dilution, followed by a HRP Polymer for Mouse IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

  • 免疫细胞化学

    • ICC shows positive staining in MCF7 cells. Anti-BRCA1 antibody was used at 1/2000 dilution (Green) and incubated overnight at 4°C. Goat polyclonal Antibody to Mouse IgG - H&L (Alexa Fluor® 488) was used as secondary antibody at 1/1000 dilution. The cells were fixed with 100% ice-cold methanol and permeabilized with 0.1% PBS-Triton X-100. Nuclei were counterstained with DAPI (Blue). Counterstain with tubulin (Red).

  • 组织表达图谱

    • Expression of BRCA1 in tumor tissues.

    • Expression of BRCA1 in human tissues.

    • Expression of BRCA1 in human breast tumor tissues.

评论(0)